Advanced DPP-4 Innovation
Advanced DPP-4 inhibition mechanism for superior glucose-dependent insulin regulation and enhanced pancreatic function in Type 2 diabetes mellitus patients.
Why Choose Sitakreios
Advanced DPP-4 Innovation for Diabetes Management
Discover the clinical advantages of Sitakreios DPP-4 inhibitor range for effective Type 2 diabetes mellitus treatment
Weight Neutral Therapy
Weight-neutral therapy with low risk of hypoglycemia and excellent patient compliance for long-term diabetes management and improved quality of life.
Modern Pharmaceutical Technology
Cutting-edge pharmaceutical technology with precision manufacturing and comprehensive quality assurance following WHO-GMP standards.
Complete Range
Sitakreios Product Portfolio
Comprehensive DPP-4 inhibitor solutions tailored for different patient needs and diabetes management protocols
Scientific Excellence
Advanced DPP-4 Technology
Our Sitakreios range employs cutting-edge DPP-4 inhibition technology to deliver optimal therapeutic outcomes with enhanced safety and patient compliance.
DPP-4 Selective Inhibition
Selective inhibition of DPP-4 enzyme enhances incretin hormone levels for glucose-dependent insulin secretion.
Cardiovascular Safety
Proven cardiovascular safety profile with neutral to beneficial effects on heart health and weight management.
Sustained Efficacy
Long-lasting glucose control with minimal risk of hypoglycemia and excellent long-term safety profile.
Key Active Ingredients
Sitagliptin
DPP-4 Inhibitor
50-100mg
Metformin HCl
Insulin Sensitizer
500-1000mg
Dapagliflozin
SGLT-2 Inhibitor
5-10mg
Clinical Efficacy
Up to 1.5% reduction in HbA1c levels with minimal hypoglycemia risk and excellent cardiovascular safety
Clinical Excellence
Proven Clinical Benefits
97%
Patient Satisfaction
High patient compliance and satisfaction rates with minimal side effects
1.5%
HbA1c Reduction
Significant improvement in glycemic control with DPP-4 inhibition
Low
Hypoglycemia Risk
Minimal risk of hypoglycemia due to glucose-dependent mechanism
98%
Safety Profile
Excellent safety and tolerability in long-term clinical studies
Diabetes Management
Type 2 Diabetes Mellitus Benefits of Sitakreios Tablet
In Type 2 Diabetes Mellitus
Type 2 diabetes mellitus is a long-term condition where the body either does not produce enough insulin or does not use it effectively, leading to high blood sugar levels.
How Sitakreios 50mg Tablet Helps:
- Increases insulin release from pancreatic beta cells
- Decreases sugar production in the liver
- Improves overall blood sugar control
- Reduces diabetes-related complications
This improves overall blood sugar control and reduces diabetes-related complications.
Advanced Mechanism
1
DPP-4 Inhibition
Blocks DPP-4 enzyme action2
Incretin Enhancement
Increases GLP-1 and GIP levels3
Glucose Control
Reduces blood sugar levels
Frequently Asked Questions